แปลจากภาษาอังกฤษ-

During the past decade, Prapokklao Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prapokklao Hospital" #1 sponsor was "Institut de Recherche pour le Developpement" with 7 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "The HIV Netherlands Australia Thailand Research Collaboration" with 2 trials sponsored, "Achieve Life Sciences" with 1 trials sponsored and "Arcus Biosciences, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prapokklao Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Harvard School of Public Health (HSPH)" with 2 trials as a collaborator, "Ministry of Health, Thailand" with 2 trials as a collaborator and "Bamrasnaradura Infectious Diseases Institute" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Prapokklao Hospital" are "HIV Infections" (5 trials), "Pregnancy" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Cervical Cancer" (1 trials) and "HIV" (1 trials). Many other conditions were trialed in "Prapokklao Hospital" in a lesser frequency.

Most popular intervention types in "Prapokklao Hospital" are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "Lopinavir/ritonavir" (2 trials), "Anti-HBV antiviral prophylaxis" (1 trials), "Atezolizumab" (1 trials), "Carboplatin" (1 trials) and "Custirsen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prapokklao Hospital" are 9 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Prapokklao Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Prapokklao Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Prapokklao Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".